Related Experiment Video
Updated: Feb 4, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Shortened IV Antibiotic Course for Uncomplicated, Late-Onset Group B Streptococcal Bacteremia
Eric R Coon1,2, Raj Srivastava3,2,4, Greg Stoddard2,5
1Division of Inpatient Medicine, eric.coon@hsc.utah.edu.
Insights
Shortened intravenous antibiotic courses for infant group B Streptococcus bacteremia are common and show low recurrence rates. This suggests current guidelines may be longer than necessary for uncomplicated cases.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neonatology
Background:
- Guidelines recommend 10-day intravenous (IV) antibiotic therapy for infants with uncomplicated, late-onset group B Streptococcus (GBS) bacteremia.
- Variability exists in the duration of IV antibiotic treatment prescribed for GBS bacteremia.
Purpose of the Study:
- To determine the frequency of shortened IV antibiotic courses for GBS bacteremia in infants.
- To compare GBS disease recurrence rates between prolonged and shortened IV antibiotic courses.
Main Methods:
- Multicenter retrospective cohort study of infants (7 days to 4 months) with GBS bacteremia (2000-2015).
- Exposure: shortened IV antibiotic therapy (≤8 days length of stay without central line).
- Primary outcome: readmission for GBS bacteremia, meningitis, or osteomyelitis within the first year of life.
- Analysis: propensity-adjusted, inverse probability-weighted regression models.
Main Results:
- Of 775 infants, 21% received a shortened IV antibiotic course (≤8 days).
- Shortened course use varied significantly by hospital (0%-67%).
- GBS recurrence rates were similar: 1.8% for shortened courses vs. 2.3% for prolonged courses (adjusted risk difference: -0.2%).
Conclusions:
- Shortened IV antibiotic courses are frequently prescribed for uncomplicated, late-onset GBS bacteremia.
- Low rates of GBS recurrence and treatment failure were observed with shortened courses.
Abstract:
: media-1vid110.1542/5804909691001PEDS-VA_2018-0345Video Abstract BACKGROUND: Guidelines recommend a prolonged course (10 days) of intravenous (IV) antibiotic therapy for infants with uncomplicated, late-onset group B Streptococcus (GBS) bacteremia. Our objective was to determine the frequency with which shorter IV antibiotic courses are used and to compare rates of GBS disease recurrence between prolonged and shortened IV antibiotic courses.
Methods:
We performed a multicenter retrospective cohort study of infants aged 7 days to 4 months who were admitted to children's hospitals in the Pediatric Health Information System database from 2000 to 2015 with GBS bacteremia. The exposure was shortened IV antibiotic therapy, defined as discharge from the index GBS visit after a length of stay of ≤8 days without a peripherally inserted central catheter charge. The primary outcome was readmission for GBS bacteremia, meningitis, or osteomyelitis in the first year of life. Outcomes were analyzed by using propensity-adjusted, inverse probability-weighted regression models.
Results:
Of 775 infants who were diagnosed with uncomplicated, late-onset GBS bacteremia, 612 (79%) received a prolonged IV course of antibiotic therapy, and 163 (21%) received a shortened course. Rates of treatment with shortened IV courses varied by hospital (range: 0%-67%; SD: 20%). Three patients (1.8%) in the shortened IV duration group experienced GBS recurrence, compared with 14 patients (2.3%) in the prolonged IV duration group (adjusted absolute risk difference: -0.2%; 95% confidence interval: -3.0% to 2.5%).
Conclusions:
Shortened IV antibiotic courses are prescribed among infants with uncomplicated, late-onset GBS bacteremia, with low rates of disease recurrence and treatment failure.
More Related Videos
08:27Development of an Uncomplicated Mild Traumatic Brain Injury Model Modified by Weight-Drop Method and Evidenced by Magnetic Resonance Imaging
Published on: April 11, 2025
08:32Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Diversity of Archaea IV
Angina IV: Management